Hansberger Growth Investors’s Novo Nordisk NVO Stock Holding History

Hansberger Growth Investors’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-92,198	Closed	-$2.47M	–	17
2017 Q4	$2.47M	Buy	92,198 +2,850	+3%	+$72.5K	3.28%	13
2017 Q3	$2.15M	Buy	89,348 +9,248	+12%	+$209K	2.9%	12
2017 Q2	$1.72M	Buy	80,100 +14,706	+22%	+$297K	2.34%	15
2017 Q1	$1.12M	Buy	65,394 +12,556	+24%	+$219K	1.31%	18
2016 Q4	$947K	Sell	52,838 -2,520	-5%	-$45.7K	1.21%	18
2016 Q3	$1.15M	Buy	55,358 +1,722	+3%	+$42.7K	0.87%	41
2016 Q2	$1.44M	Sell	53,636 -8,972	-14%	-$246K	1.12%	38
2016 Q1	$1.7M	Buy	62,608 +3,984	+7%	+$107K	1.14%	33
2015 Q4	$1.7M	Buy	58,624 +1,732	+3%	+$47.9K	1.19%	32
2015 Q3	$1.54M	Buy	56,892 +1,946	+4%	+$55.1K	1.1%	33
2015 Q2	$1.5M	Sell	54,946 -49,884	-48%	-$1.4M	1.03%	36
2015 Q1	$2.8M	Sell	104,830 -8,744	-8%	-$201K	1.08%	34
2014 Q4	$2.4M	Buy	+113,574	New	+$2.54M	0.74%	41

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Hansberger Growth Investors's NVO Position: Q1 2018 in Review

Hansberger Growth Investors sold out of Novo Nordisk (NVO) in Q1 2018, closing a stake of 92,198 shares — an estimated $2.47M sold.

Hansberger Growth Investors first reported a position in NVO in Q4 2014 and held it in 13 quarters. The position peaked at $2.8M in Q1 2015. 553 funds tracked by Wall St. Rank hold NVO as of Q1 2018.

Hansberger Growth Investors reported no remaining Novo Nordisk position as of Q1 2018 after selling out during the quarter.
Hansberger Growth Investors sold 92,198 Novo Nordisk shares in Q1 2018, an estimated $2.47M.
Hansberger Growth Investors first reported a position in Novo Nordisk in Q4 2014 and held it in 13 quarters.
Hansberger Growth Investors's Novo Nordisk position peaked at $2.8M in Q1 2015.
553 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2018.

Based on Hansberger Growth Investors's 13F filing for Q1 2018, filed 11 May 2018.